NCT06115460View on ClinicalTrials.gov

The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 15, 2023

Conditions
Type 1 Diabetic Nephropathy
Interventions
DRUG

oral sitagliptin supplementation

oral sitagliptin supplementation for three months

Trial Locations (1)

11361

Nancy Elbarbary, Cairo

All Listed Sponsors
collaborator

Ahram Canadian University

OTHER

lead

Ain Shams University

OTHER